As expected, immunohistochemistry demonstrated a notable increase in CD3+CD8+ double-positive T lymphocytes within the Se@MI-treated group, indicating an enhanced infiltration of CTLs into the tumor milieu. This evidence concerns the gene CD8A and neoplasm.